These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2200891)

  • 1. Preleukemic hematopoietic hyperplasia induced by Moloney murine leukemia virus is an indirect consequence of viral infection.
    Brightman BK; Davis BR; Fan H
    J Virol; 1990 Sep; 64(9):4582-4. PubMed ID: 2200891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nonleukemogenic and wild-type Moloney murine leukemia virus on lymphoid cells in vivo: identification of a preleukemic shift in thymocyte subpopulations.
    Davis BR; Chandy KG; Brightman BK; Gupta S; Fan H
    J Virol; 1986 Nov; 60(2):423-30. PubMed ID: 3490580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a preleukemic state induced by Moloney murine leukemia virus: evidence for two infection events during leukemogenesis.
    Davis BR; Brightman BK; Chandy KG; Fan H
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4875-9. PubMed ID: 3474632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An enhancer variant of Moloney murine leukemia virus defective in leukemogenesis does not generate detectable mink cell focus-inducing virus in vivo.
    Brightman BK; Rein A; Trepp DJ; Fan H
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2264-8. PubMed ID: 2006167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow depletion by 89Sr complements a preleukemic defect in a long terminal repeat variant of Moloney murine leukemia virus.
    Li QX; Fan H
    J Virol; 1991 Aug; 65(8):4442-8. PubMed ID: 1649340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice.
    Brightman BK; Okimoto M; Kulkarni V; Lander JK; Fan H
    Virology; 1998 Mar; 242(1):60-7. PubMed ID: 9501051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.
    Brightman BK; Farmer C; Fan H
    J Virol; 1993 Dec; 67(12):7140-8. PubMed ID: 8230436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant mink cell focus-inducing virus and long terminal repeat alterations accompany the increased leukemogenicity of the Mo+PyF101 variant of Moloney murine leukemia virus after intraperitoneal inoculation.
    Belli B; Patel A; Fan H
    J Virol; 1995 Feb; 69(2):1037-43. PubMed ID: 7815481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined infection by Moloney murine leukemia virus and a mink cell focus-forming virus recombinant induces cytopathic effects in fibroblasts or in long-term bone marrow cultures from preleukemic mice.
    Li QX; Fan H
    J Virol; 1990 Aug; 64(8):3701-11. PubMed ID: 2164592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appearance of mink cell focus-inducing recombinants during in vivo infection by moloney murine leukemia virus (M-MuLV) or the Mo+PyF101 M-MuLV enhancer variant: implications for sites of generation and roles in leukemogenesis.
    Lander JK; Chesebro B; Fan H
    J Virol; 1999 Jul; 73(7):5671-80. PubMed ID: 10364317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
    Fan H; Mittal S; Chute H; Chao E; Pattengale PK
    J Virol; 1986 Oct; 60(1):204-14. PubMed ID: 3747027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The leukemogenic potential of an enhancer variant of Moloney murine leukemia virus varies with the route of inoculation.
    Belli B; Fan H
    J Virol; 1994 Nov; 68(11):6883-9. PubMed ID: 7933068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moloney murine leukemia virus-induced preleukemic thymic atrophy and enhanced thymocyte apoptosis correlate with disease pathogenicity.
    Bonzon C; Fan H
    J Virol; 1999 Mar; 73(3):2434-41. PubMed ID: 9971828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of a GC-rich region flanking the enhancer element within the long terminal repeat sequences alters the disease specificity of Moloney murine leukemia virus.
    Hanecak R; Pattengale PK; Fan H
    J Virol; 1991 Oct; 65(10):5357-63. PubMed ID: 1895389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemogenicity of Moloney murine leukemia viruses carrying polyoma enhancer sequences in the long terminal repeat is dependent on the nature of the inserted polyoma sequences.
    Fan H; Chute H; Chao E; Pattengale PK
    Virology; 1988 Sep; 166(1):58-65. PubMed ID: 2842957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multistep process of leukemogenesis in Moloney murine leukemia virus-infected mice that is modulated by retroviral pseudotyping and interference.
    Lavignon M; Evans L
    J Virol; 1996 Jun; 70(6):3852-62. PubMed ID: 8648721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moloney murine leukemia virus infects cells of the developing hair follicle after neonatal subcutaneous inoculation in mice.
    Okimoto MA; Fan H
    J Virol; 1999 Mar; 73(3):2509-16. PubMed ID: 9971836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific replication of Friend and Moloney murine leukemia viruses in infected mice.
    Evans LH; Morrey JD
    J Virol; 1987 May; 61(5):1350-7. PubMed ID: 3033265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the viral sequences conferring leukemogenicity and disease specificity in Moloney and amphotropic murine leukemia viruses.
    DesGroseillers L; Jolicoeur P
    J Virol; 1984 Nov; 52(2):448-56. PubMed ID: 6092670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of a recombinant Moloney murine leukemia virus containing the v-myc oncogene of avian MC29 virus: in vitro transformation and in vivo pathogenesis.
    Brightman BK; Pattengale PK; Fan H
    J Virol; 1986 Oct; 60(1):68-81. PubMed ID: 3018301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.